Kurt Vogtli

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
AICURIS ANTI-INFECTIVE CURES GMBH
4
2015
ASTRAZENECA AB
2
2004
AICURIS GMBH & CO. KG
2
2
2
2012
2013
2015

Inventor Addresses

AddressDuration
Aarau, CHDec 18, 08 - Jun 14, 11
Oberhofen AG, CHMar 06, 14 - Nov 27, 18
Oberhofen, CHAug 07, 14 - Oct 17, 23

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5
C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS 1
C07D: HETEROCYCLIC COMPOUNDS 7

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
RE496972023Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations0
101371172018Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations6
98891242018Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations6
95922252017Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations7
93405352016N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate5

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.